Biotechnology

Filter

Current filters:

None

Popular Filters

27 to 51 of 2289 results

Rigel’s R348 fails to meet endpoints in Ph II dry eye study

13-08-2014

Clinical-stage US drug developer Rigel Pharmaceuticals says that R348, its ophthalmic JAK/SYK inhibitor,…

BiotechnologyDry eye diseasefostamatinibOphthalmicsR118R348ResearchRigel Pharmaceuticals

TNI BioTech and Hubei Qianjiang link up on cancer drug development

TNI BioTech and Hubei Qianjiang link up on cancer drug development

13-08-2014

US biotech firm TNI BioTech has signed a supplemental agreement with China’s Hubei Qianjiang Pharmaceutical…

BiotechnologyBusiness FinanceChinaHubeiLicensingOncologyQianjiang PharmaceuticalResearchTNI BioTechUSA

Dendreon shares fall as company warns of worry over debt repayment

Dendreon shares fall as company warns of worry over debt repayment

13-08-2014

Shares of US biotech firm Dendreon have fallen after it warned shareholders about debt problems.

BiotechnologyBusiness FinanceCancer vaccinesDendreonFinancialProvengeSipuleucel-TUSA

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

Oxis looking to enter cannabis biotech sector

Oxis looking to enter cannabis biotech sector

11-08-2014

USA-based Oxis International, currently working on products around the effects of oxidative stress, is…

BiotechnologyEntheogensMedical cannabisOxisProductionUSA

FDA issues new biosimilars guidance on exclusivity

FDA issues new biosimilars guidance on exclusivity

11-08-2014

The US Food and Drug Administration has announced the availability of a draft guidance for industry titled…

BiosimilarsBiotechnologyFinancialRegulationUSA

Galapagos plunges as GSK gives up rights to developmental drug

09-08-2014

Along with presenting first-half 2014 financial results today, Belgian biotech group Galapagos said its…

BiotechnologyFinancialGalapagosGlaxoSmithKlineGSK2586184Inflammatory diseasesLicensing

Genentech files sBLA for Lucentis for diabetic retinopathy

09-08-2014

Genentech, the biotech subsidiary of Swiss pharma major Roche, has submitted a supplemental Biologics…

BiotechnologyGenentechLucentisOphthalmicsRegulationRocheUSA

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

IQWiG finds no added benefit for Biogen Idec’s Tecfidera

08-08-2014

In its early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG)…

Biogen IdecBiotechnologyGermanyMSNeurologicalPricingRegulationTecfidera

Baxter opens its first state-of-the-art biologics facility in Asia

Baxter opens its first state-of-the-art biologics facility in Asia

08-08-2014

US drugmaker Baxter International has formally opened its S$370 million ($297 million) first advanced…

AdvateBaxter InternationalBiotechnologyEuropean Medicines AgencyHematologyHemophilia BProductionSingapore

EU approval for Octapharma's Nuwiq across all age groups in hemophilia A

EU approval for Octapharma's Nuwiq across all age groups in hemophilia A

07-08-2014

The European Commission has approved independent Swiss biotech firm Octapharma's Nuwiq (simoctocog alfa)…

BiotechnologyEuropeHematologyNuwiqOctapharmaRegulation

AusBiotech calls for greater culture of innovation and infrastructure in Australian Senate inquiry

AusBiotech calls for greater culture of innovation and infrastructure in Australian Senate inquiry

07-08-2014

AusBiotech, a body representing the biotechnology industry in Australia, has called for a greater culture…

AustraliaAustralian senateBiotechnologyBiotechnology industryRegulation

Cubist Pharmaceuticals voluntarily recalls Cubicin lots in the USA

Cubist Pharmaceuticals voluntarily recalls Cubicin lots in the USA

06-08-2014

American biopharmaceutical company Cubist has issued a voluntary recall of certain lots of Cubicin (daptomycin…

Antibiotics and Infectious diseasesBiotechnologyCubicinCubist PharmaceuticalsPhlebitisRegulationThromboembolismUSA

Eylea drives Regeneron’s 2nd-qtr to beat expectations

Eylea drives Regeneron’s 2nd-qtr to beat expectations

05-08-2014

USA-based biotech company Regeneron (Nasdaq: REGN) revealed today that total revenues for the second…

BiotechnologyBusiness FinanceEyleaFinancialOphthalmicsRegeneronUSA

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

Regulus shares up on deal with Biogen for microRNA biomarkers in MS

05-08-2014

Regulus Therapeutics has entered into a new collaboration agreement with fellow US biotech firm Biogen…

Biogen IdecBiotechnologyMultiple sclerosisNeurologicalRegulus TherapeuticsResearchUSA

27 to 51 of 2289 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top